Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sigmoid Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Fractures, Bone 1Emergence Delirium 1Colonic Neoplasms 1

Interventions

Sorafenib 42Bevacizumab 26Oxaliplatin 21Radiosurgery 19Gemcitabine 17Fluorouracil 15Hepatectomy 13lenvatinib 12Radiofrequency Ablation 11Nivolumab 11Cisplatin 11Radiotherapy 10Doxorubicin 10Capecitabine 10durvalumab 9Leucovorin 9Blood Specimen Collection 9atezolizumab 8Liver Transplantation 8Everolimus 7Electroporation 7pembrolizumab 6camrelizumab 6Sunitinib 6Immunohistochemistry 6Cryosurgery 6Carboplatin 6tremelimumab 5sintilimab 5apatinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Liver Neoplasms × Neuroleptanalgesia × Clear all
NCT05068180 2021-10-06

Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients

RenJi Hospital

Phase 4 Unknown
200 enrolled
GastrointestinalGenitourinary

Emergence Delirium, Urinary Bladder Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Liver Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sigmoid Neoplasms, Stomach Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡